Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 36% ± 8% | |
hepatocyte | 3 studies | 50% ± 21% |
Insufficient scRNA-seq data for expression of CREB3L3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 36369.67 | 226 / 226 | 94% | 239.71 | 383 / 406 |
kidney | 81% | 143.90 | 72 / 89 | 53% | 14.76 | 480 / 901 |
adrenal gland | 97% | 680.87 | 250 / 258 | 10% | 0.81 | 22 / 230 |
stomach | 50% | 50.47 | 181 / 359 | 42% | 9.15 | 119 / 286 |
intestine | 57% | 1909.45 | 549 / 966 | 27% | 3.72 | 144 / 527 |
brain | 66% | 42.14 | 1749 / 2642 | 0% | 0.02 | 3 / 705 |
pancreas | 31% | 43.64 | 102 / 328 | 33% | 5.25 | 58 / 178 |
esophagus | 11% | 7.47 | 165 / 1445 | 30% | 7.92 | 54 / 183 |
spleen | 37% | 44.22 | 89 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 33% | 25.27 | 307 / 929 | 0% | 0 | 0 / 0 |
lung | 20% | 4.59 | 118 / 578 | 8% | 1.85 | 92 / 1155 |
bladder | 10% | 1.10 | 2 / 21 | 7% | 0.37 | 35 / 504 |
ovary | 15% | 12.80 | 27 / 180 | 0% | 0.01 | 1 / 430 |
thymus | 6% | 1.62 | 40 / 653 | 6% | 0.30 | 39 / 605 |
uterus | 11% | 3.35 | 18 / 170 | 1% | 0.25 | 6 / 459 |
adipose | 12% | 6.01 | 143 / 1204 | 0% | 0 | 0 / 0 |
breast | 11% | 5.95 | 52 / 459 | 0% | 0.22 | 4 / 1118 |
prostate | 10% | 1.87 | 24 / 245 | 0% | 0.01 | 1 / 502 |
blood vessel | 5% | 1.07 | 61 / 1335 | 0% | 0 | 0 / 0 |
skin | 4% | 1.98 | 73 / 1809 | 0% | 0.01 | 1 / 472 |
muscle | 3% | 0.56 | 26 / 803 | 0% | 0 | 0 / 0 |
heart | 3% | 0.95 | 25 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006986 | Biological process | response to unfolded protein |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0002675 | Biological process | positive regulation of acute inflammatory response |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CREB3L3 |
Protein name | Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3] |
Synonyms | HYST1481 CREBH |
Description | FUNCTION: Transcription factor that may act during endoplasmic reticulum stress by activating unfolded protein response target genes. Activated in response to cAMP stimulation. In vitro, binds to the cAMP response element (CRE) and box-B element. Activates transcription through box-B element. Activates transcription through CRE (By similarity). May function synergistically with ATF6. In acute inflammatory response, may activate expression of acute phase response (APR) genes. May be involved in growth suppression. Regulates FGF21 transcription (By similarity). Plays a crucial role in the regulation of triglyceride metabolism and is required for the maintenance of normal plasma triglyceride concentrations . . |
Accessions | ENST00000602147.1 [Q68CJ9-5] ENST00000078445.7 [Q68CJ9-1] Q68CJ9 ENST00000595923.5 [Q68CJ9-2] ENST00000602257.5 [Q68CJ9-4] |